Home -> Law Blog Directory -> Intellectual Property Law Blogs -> IPKat
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: IPKatSpanish fly in the ointment spoils EU patent dreams
By Johanna Gibson, David Pearce, Jeremy Phillips and Ilanah Simon.
Some folk say that the non-existence of an appropriate protection that's also acceptable in terms of costs puts Europe's businesses at a great disadvantage against the US, Japan and China -- but the Kat, without expressing a formal opinion at this point, would like to know precisely why this is so, since the European, US, Japanese and Chinese patent systems are level playing fields that operate the same way for patent applicants (and opponents) of all nationalities. At present the 27 EU nations currently share 23 official languages; numerous proposals and compromises have either failed to satisfy political demands or have risked increasing translation costs for businesses. Spain is said to be the main culprit but this Kat feels sure that, if Spain had not gone to great lengths to fight for a more elastic language regime, one or two other countries would not have had the luxury of hiding behind their Iberian brethren and would have had to attract the opprobrium themselves.
Fly in the ointment here
Spanish fly here
Full post as published by IPKat on November 11, 2010 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment
Qualcomm Settles Patent Suit for $891 Million
The Princeton Review
$2.6 million settlement reached in patent infringement case.

Law Firms Fighting Over Contingency Spoils
Dementia patients coated in ointment, workers charged
Joint Defense or Research Joint Venture Reassessing the Patent-Challenge-Bloc's Antitrust Status








